ANTHRAX

 

AIGIV™
[Anthrax Immune Globulin Intravenous (Human)]
Therapeutic Candidate



AIGIV™ [Anthrax Immune Globulin Intravenous (Human)] is being studied for use against symptomatic anthrax infection. It is derived from pooled sera of humans previously vaccinated with BioThrax® (Anthrax Vaccine Adsorbed) and contains human polyclonal antibodies.


Completed Clinical Trials  LEARN MORE